CTLA4 +49G allele in combination with HLA-DR3 associates with type 1 diabetes as well as its onset in North Indians

Authors:
  • KGKaur Gurvinder
    Kaur Gurvinder
  • KUKanga Uma
    Kanga Uma
  • TNTandon Nikhil
    Tandon Nikhil
  • ZSZucman Sophie
    Zucman Sophie
  • MNMehra Narinder
    Mehra Narinder

Abstract
Type 1 diabetes is a complex autoimmune disease with a strong genetic influence. We have investigated the role of the CTLA4 (Cytotoxic T-lymphocyte associated antigen -4) exon 1 A49G polymorphism and its role as a risk factor for T1D in the North Indian population. We studied 232 type 1 diabetic patients and 200 healthy controls by PCR amplification followed by restriction enzyme digestion with FnU4HI. Allele G at +49 position in codon1 of CTLA 4 gene was significantly increased in type 1 diabetic patients as compared to that in healthy controls (37.3% in patients vs 29% in controls, p= 0.012, OR=1.46, 95%CI= 1.09-1.94 ). Further, the frequency of homozygous GG genotype was significantly increased among patients than controls (15.5% vs 5.0%, p=0.001, OR=3.49 (95% CI=1.7-7.13)). The patients with younger age at onset of disease (<14 years) had a significantly high frequency of G positive genotypes (A/G or G/G) than those with an older age at onset of disease (≥14 years) (66% vs 47.1%, p=0.007, OR=2.18 (95%CI=1.27-3.76). Further analysis involving the HLA data revealed that the CTLA4 +49G allele is not in linkage disequilibrium with the reported susceptible HLA-DR3 allele, however the susceptibility conferred by +49G allele as well as its effect on the disease onset was observed to be dependent on the presence of HLA-DR3 allele. These results suggest that CTLA4 +49G allele in the presence of HLA-DR3 allele not only confers susceptibility to T1D and but is a strong marker for acceleration of disease development